For real-time updates on NTEC, beat the news and login or try Benzinga Pro.
Intec Pharma NTEC today had a large opening gap of -453.70%.
Photo taken from the Opening Gap Signals tool inside Benzinga Pro.
Why Is NTEC Moving?
Intec Pharma shares are trading lower after the company announced its Phase 3 trial of Accordion Pill-Carbidopa/Levodopa in advanced parkinson’s disease patients did not meet its target endpoints.
Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.
For live updates on NTEC log in or try Benzinga Pro today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.